Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, March 3, 2022

Endovascular treatment for acute basilar artery occlusion: A multicenter randomized controlled trial (ATTENTION)

Wrong goal.

Still a ways to go, mRS score should be zero(No symptoms) for all treated. Until we get researchers to shoot for the correct goal, 100% recovery, all stroke survivors will be screwed now and forever.

Endovascular treatment for acute basilar artery occlusion: A multicenter randomized controlled trial (ATTENTION)

Show all authors
Chunrong Tao*, Rui Li*, Yuyou Zhu, ...
First Published February 22, 2022 Research Article Find in PubMed 
https://doi.org/10.1177/17474930221077164

Abstract

Background and hypothesis:

Recently, two multicenter randomized controlled trials (RCT) failed to show a significantly beneficial effect of endovascular treatment (EVT) in patients with acute basilar artery occlusion (BAO). However, both trials suffered from equipoise issues which may have hindered the validity of the trial results. Therefore, additional RCT studies are needed to explore the potential benefit of EVT in patients presenting with BAO.

Study design:

ATTENTION is an investigator-initiated, multicenter, prospective, randomized, controlled clinical trial with open-label treatment and blinded outcome assessment (PROBE) of EVT versus best medical management (BMM). The primary effect parameter is a modified Rankin Score of 0–3 at day 90.

Discussion:

ATTENTION will provide evidence for the efficacy and safety of EVT in stroke patients within 12 h after BAO.

Trial registration:

ClinicalTrials.gov NCT04751708

Keywords
 
Posted by at
Labels: , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)